FDA continues prowl for COVID-19 product claims with warning letter to 8th CBD company

Premium CBD Products


CBD 20% Discount

Since the beginning of March, federal food and drug regulators have issued warning letters to 64 companies for selling products under claims that they will prevent, treat, mitigate diagnose or cure COVID-19.

To date, the U.S. Food and Drug Administration had sent eight of those letters to CBD companies, including:

May 26: CBD Gaze, a Puerto Rico-based companyMay 15: Noetic Nutraceuticals, Columbia, Maryland; in corrective statusMay 7: Agro Terra, d/b/a Patriot Hemp Company, Lyons, ColoradoApril 16: Nova Botanix, d/b/a CanaBD, London, United KingdomApril 7: CBD Online Store, Laguna Hills, California; in corrective statusApril 6: Native Roots Hemp, Algoma, Wisconsin; in corrective statusApril 6: Indigo Naturals, Carmel Valley, CaliforniaMarch 31: Neuro XPF, Las Vegas, Nevada; in corrective status

According to the FDA’s website tracking warning letters to firms marketing products related to coronavirus, the agency continues to actively monitor for “any firms marketing products with fraudulent COVID-19 prevention and treatment claims.

The site includes information for reporting websites that illegally sell human drugs, animal drugs, medical devices, biological products, foods, dietary supplements and cosmetics.

The agency said action against companies making false or misleading claims will include warning letters, product seizures or injunctions against products and firms or individuals who violate the law.

Thanks for joining us today for our latest news update. If you have any questions or comments about this post, we’d love to hear from you in the comments! Join the FindHempCBD.com newsletter to stay up to date on the latest Industry News and check back soon for our next news story!

Disclaimer: This content was was sourced and duplicated from HempIndustryDaily.com. In order to maintain the safety, functionality, and integrity of FindHempCBD.com, the sourced content may have been altered. To access the original content, please click the link below:
FDA continues prowl for COVID-19 product claims with warning letter to 8th CBD company

Comments

mood_bad
  • No comments yet.
  • chat
    Add a comment